drugset
drugset / Press release

Data from MacroGenics' Ongoing Phase 1 Study of Enoblituzumab (MGA271) Presented at 30th Annual SITC Meeting 2015

2015-11-07 · MacroGenics · original macrogenics.com ↗

Enoblituzumab

Data from MacroGenics' Ongoing Phase 1 Study of Enoblituzumab (MGA271) Presented at 30th Annual SITC Meeting 2015 18.1 KB

The release as fetched from its publisher. macrogenics.com ↗